REGENERON PHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for REGENERON PHARMACEUTICALS OPTION, CUSIP REGNXXXXX.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for REGENERON PHARMACEUTICALS OPTION, CUSIP REGNXXXXX.